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Abstract
Background: Postcode lotteries in health refer to differences in health care between different geographic areas.
These have been previously associated with clinical services. However there has been little documentation of
postcode lotteries relating to preventative health care services. This paper describes a postcode lottery effect in
relation to the NHS Health Checks Programme (a national cardiovascular screening programme in England) in
eight PCTs in the North West sector of London.
Methods: A descriptive cross-sectional analysis of the Health Checks Programme was carried out in eight PCTs in
North West London using a structured data-collecting instrument.
Results: The analysis found variation in the implementation of the national Health Checks Programme in terms of:
the screening approach taken; the allocated budget (which varied from £69,000 to £1.4 million per 100,000 eligible
population); payment rates made to providers of Health Checks; tools used to identify and measure risk of
cardiovascular disease and diabetes; monitoring and evaluation; and preventative services available following the
health check.
Conclusions: This study identifies a postcode lottery effect related to a national public health programme.
Although it is important to allow enough flexibility in the design of the Health Checks Programme so that it fits in
with local factors, aspects of the programme may benefit from greater standardisation or stronger national
guidance.
Background
Postcode lotteries in health refer to variations in health
care between different geographical areas that appear arbi-
trary and un-linked to health need. The term is usually
associated with clinical services and has been used in rela-
tion to out-of-hospital cardiac arrest response rates [1],
access to cancer treatments [2], access to surgery [3], and
access to specialist palliative care [4]. However, there has
been little documentation of postcode lotteries related to
public health programmes.
This paper describes a ‘postcode lottery’ effect in relation
to the NHS Health Checks Programme which was intro-
duced in 2009 by the Department of Health (DH) to pro-
vide population-wide screening for cardiovascular disease
(CVD). Vascular diseases make up a third of the difference
in life expectancy between spearhead areas and the rest of
England [5] the Health Checks Programme therefore
offers an opportunity to reduce health inequalities. Adults
aged between 40 and 74 (with no prior diagnosed vascular
disease) are screened to assess their risk of a cardiovascu-
lar event in the next 10 years and are provided with a
combination of advice and medication as required. The
national programme aims to achieve full coverage of the
target population over a five year period.
The funding and delivery of the programme has been
delegated to Primary Care Trusts (PCTs) in England, pub-
lic sector organisations that are responsible for commis-
sioning health services for the population of a defined
catchment area. Although national guidelines exist to help
ensure some degree of quality assurance, consistency and
standardisation (Table 1) [6], PCTs are expected to design
and deliver the programme in a way that suits local cir-
cumstances. The freedom that PCTs have in the funding,
design and implementation of their local Health Checks
Programme allows for considerable variation to emerge
across the country. In order to examine the nature and
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of the Health Checks Programme in each of the eight
PCTs in North West London.
Methods
A cross-sectional study of the Health Checks Programme
in each PCT in North West London was conducted
between 2
nd September and 16
th September 2010. Data
were collected using a structured questionnaire which
covered the following aspects of the Health Checks Pro-
gramme: eligibility criteria; approach used to ensure
population coverage; funding and associated payment
structures; equipment and screening instruments; CVD
risk calculation tool used; additional interventions; moni-
toring and evaluation; and advice, treatment and referrals
(this questionnaire used can be found in additional file
1). The questionnaire was completed by the Health
Check lead of each PCT. Any additional data or clarifica-
tions were obtained via email. Consent to publish the
data received was obtained from Health Check Leads and
Directors of Public Health. The data collected for this
study are available on request.
Results
Eligibility
Most PCTs followed the national guidance on eligibility
although in the first year of their programme, two PCTs
had extended the lower age limit to 35 years for indivi-
duals from high risk communities, while one PCT had
reduced the upper age limit to 70 years. However, incon-
sistency in the way ‘pre-existing CVD’ was defined resulted
in differences in eligibility: national guidance had not spe-
cified whether patients with hypertension and atrial fibril-
lation, or patients already on statin medication should be
included or excluded from the Health Checks Programme.
Since this study was conducted, further clarification has
been provided on the definition of ‘pre existing CVD’
which now includes those who have been diagnosed with
coronary heart disease, chronic kidney disease, diabetes,
hypertension, atrial fibrillation, transient ischemic attack,
familial hypercholesterolemia, heart failure, peripheral
arterial disease or peripheral vascular disease or those pre-
scribed statins.
All eight PCTs defined their base population according
to individuals registered with their local GP practices;
however, two PCTs also allowed patients who were resi-
dent in the borough but registered with GP practices
elsewhere.
Approach to Achieving Population Coverage
A systematic approach to achieving population coverage,
primarily through the provision of health checks in GP
surgeries, was adopted by all the PCTs. However, in three
PCTs, the eligible population was stratified into five
groups (one for each of the 5 years allocated to achieve
full coverage) according to an estimated risk of CVD
based on markers of CVD obtained from GP records. The
group with the highest risk of individuals were prioritised
and invited to have a health check in the first year of the
programme, followed each year by the group with the next
highest set of risks. In the other five PCTs, patients were
allocated into groups randomly.
In five PCTs, health checks were also carried out
opportunistically in a number of settings. These settings
included community pharmacies (in four PCTs), and
community events at locations such as faith centres,
workplaces and shopping centres (in five PCTs). Overall,
three PCTs offered health checks only in GP practices.
One of these previously carried out health checks oppor-
tunistically at community events in the first year of the
programme this was stopped in the second year. Four
PCTs also offered health checks in GP practices, pharma-
cies and at community events (see Table 2). Health
checks carried out in community pharmacies and at out-
reach events tended to be used by PCTs as a means of
getting to hard-to-reach or deprived individuals.
Funding and Payment Structures
There was considerable variation in the budget made
available by individual PCTs for the Health Checks
Table 1 National Health Checks Guidelines
1. People aged 40 to 74 who have not been diagnosed with heart disease, stroke, kidney disease or diabetes will be invited to have a check once
every 5 years.
2. It is expected that one fifth of the eligible population will be invited for a check each year.
3. Health checks must be carried out face to face in an area that allows for privacy.
4. The person carrying out the check must have had adequate training.
5. The health check should be carried out with suitably calibrated equipment.
6. The health check should consist of: clinical history (age, gender, smoking status, family history of Coronary heart disease and ethnicity); measure
of Body Mass Index (BMI), blood cholesterol and blood pressure (BP); and a screening test for diabetes.
7. CVD risk should be calculated using an appropriate risk engine calculator as advised by NICE (either Framingham or QRISK2).
8. Everybody who undergoes a health check should have their risk conveyed to them.
SOURCE: (DH, 2008).
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100,000 eligible population (see Table 3). This allocated
budget mainly covered the cost of buying the required
equipment, paying providers to carry out the Health
Check, marketing the service and managing the pro-
gramme. Only one PCT (number 4) reported that their
budget included a behaviour change intervention.
The amount paid to individual providers also varied,
with the price paid to GP practices ranging from £13
to £40 per health check. The cost of a health check
completed in a pharmacy also varied between the high-
est and lowest paid by £10. It is not however appropri-
ate to compare the amount paid to GPs with the
amount paid to pharmacies because of the different
ways that they are funded and contracted more gener-
ally by the NHS.
Equipment and Screening Instruments
In most PCTs, health checks conducted in GP surgeries
sent blood samples for glucose and cholesterol testing
to a laboratory. Only two PCTs used Point of Care Test-
ing (POCT) in the GP setting.
Of the six PCTs conducting Health Checks in non-GP
settings, POCT equipment was used to analyse choles-
terol and glucose levels using one of two recommended
kits: cardiocheck analysers (BHR) and Cholestech LDX
analysers (Alere). There are a number of differences
between these two options, including differences in sen-
sitivity and specificity (see Table 4) and cost (with the
cardiocheck analyser costing approximately 50% and
30% cheaper than the LDX in terms of start-up and
running costs respectively). However, there was an even
split in the number of PCTs using each option.
Table 2 Eligibility Criteria and Approach Taken by PCTs
PCT Health Check
Approach
Setting Eligibility Criteria
1 Systematic GP 40-74
2 Systematic
Opportunistic
GP Year 1: 35 - 74 who are at 20% or greater risk of developing a CVD event within 10 years and
who do not already have established disease. Year 2: 40 - 74 with BMI of greater than or
equal to 30 without established disease.
3 Systematic
Opportunistic
GP
Community events
Pharmacies
Year 1: 35-74 year olds who had an estimated risk of developing CVD greater than 20% who
do not have existing disease. Year 2: 40 -74 year olds who had an estimated risk of
developing CVD greater than 20% and opportunistic for hard to reach groups.
4 Systematic GP 40-74 year-olds without pre-existing diagnosis of any of the following conditions:
hypertension, atrial fibrillation, previous TIA or stroke, hypercholesterolemia, heart failure, PAD,
CHD, diabetes, chronic kidney disease (stage3-5).
5 Systematic
Opportunistic
GP
Pharmacies
People who are aged 40 - 74 who have not been diagnosed with or treated for a vascular
disease and who are either resident in or registered with a GP.
6 Systematic
Opportunistic
GP
Community events
40 and 74 and not on a related disease register.
7 Systematic
Opportunistic
GP
Community events
Pharmacies
40 -74 year olds without pre existing diagnosis of vascular disease. Age range extended to 35
for homeless people and people with mental health needs.
8 Systematic
Opportunistic
GP
Community events
Pharmacies
40 -74 year olds without pre existing diagnosis of vascular disease. Must be registered with a
GP in the borough.
Table 3 Budget and Fee Paid per Health Check by PCT
PCT 2010-11 allocated
budget for health
checks[b]
2010-11 budget standardised
per 100,000 eligible
population
Estimated
eligible
population
(40- 74 year
olds)
Rank of
deprivation
[c]
CHD Mortality rate
in people under 75
[d]
Fee per
General
Practice HC
Fee per
Pharmacy
HC
1 £333,000 £322,349 103,304 24 45.0 £25 -
2 £350,000 £298,000 117,226 61 53.8 £16* -
3 £289,000 £532,200 54,290 31 40.1 £16 £30
4 £58,000 £69,172 83,848 184 33.6 £13 -
5 £305,000 £315,744 96,597 130 44.8 £40 £30
6 £150,000 £177,127 84,685 92 45.4 £20 -
7 £911,162 £1,404,595 64,871 98 23.2 £37 £45
8 £535,000 £681,320 78,524 75 28.9 £35 £35
*£2 extra if phlebotomy included.
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people with impaired glucose tolerance or undiagnosed
diabetes. However, national guidance is that individuals
with a high BMI (>30 (or >27 if Indian, Pakistani, Bangla-
deshi, other Asian or Chinese)) or hypertension (>140/90)
should undergo an Hb1AC or fasting blood glucose (FBG)
test. However, only one PCT followed this guidance. In
five PCTs a FBG was encouraged in all individuals who
received a health check in a GP setting, with random
blood glucose (RBG) test was allowed as an alternative in
two of these PCTs. Two PCTs used a non-invasive risk
assessment tool (FindRisc and QDScore) to determine
who should receive further testing for diabetes (See
Table 5). In community settings where health checks were
offered on an opportunistic basis using POCT all four
PCTs used random, non-fasting capillary blood samples to
test for diabetes in all patients receiving a health check,
and one used FindRisc.
CVD Risk Calculation Tools
O ft h et w oa v a i l a b l er i s kc a l c u l a t i o nt o o l s ,f o u rP C T s
used QRISK2, one PCT used JBS2, and the remaining
three used both depending on clinician choice and the
clinical management system in use in GP practices
(Table 5). Although both tools are recommended in the
national guidance, there has been much debate about
the relative strengths and weaknesses of these tools [7].
However, a recent independent validation found
QRISK2 to be marginally less sensitive but more specific
than JBS2; and to have stronger positive predictive
power. The difference can result in QRISK2 reclassifying
43% of women and 45% of men previously deemed high
risk (>20% in 10 years) by JBS2 into a low risk category
(<20% in 10 years)[8]. This would be significant in redu-
cing the cost and side-effects of unnecessary statin
prescribing.
Additional Interventions
There were differences across the eight PCTs in the way
Health checks were used as a platform and opportunity to
conduct other health interventions. For example, six PCTs
used a questionnaire to detect alcohol-related problems;
while four PCTs added a tool to measure physical activity
(Table 5). Three of the eight PCTs also used the health
check as an opportunity to do pulse examinations to
screen for atrial fibrillation.
Advice, Treatment and Referral
Once a person’s level of CVD risk has been assessed, they
should receive appropriate advice or treatment. All eight
PCTs had explicit referral criteria and pathways, with
most PCTs expecting GPs to actively manage high-risk
patients. All PCTs also referred identified smokers to a
smoking cessation service and referred or signposted
appropriate patients to weight management and exercise
programmes.
Table 4 Sensitivity and Specificity of Point of Care Testing Equipment
Sensitivity Specificity
Result Cardiocheck[e] LDX[f] Cardiocheck LDX
TC/HDL Ratio>5.0 90% 80% 74% 99%
Total Cholesterol >5.2 and or TC/HDL ratio>5.0 98% 94% 55% 89%
Total cholesterol >6.5 and TC/HDL ratio >5.0 93% 80% 85% 98%
Table 5 Screening Tools Used During the Health Check
PCT Diabetes
screening tool
(GP)
Diabetes
Screening Tool
(Community)
CVD risk
calculator
used
Additional
Screening
tests
1 BMI>30 or high BP QRISK 2
2 Fasting blood glucose QRISK 2 or
JBS 2
AF
3 Random/
Fasting Capillary blood glucose
Random capillary blood glucose JBS 2 Alcohol
Physical Inactivity
4 QDRISK QRISK 2 Alcohol
5 Fasting venous blood glucose Random capillary blood glucose QRISK 2 or
JBS 2
Alcohol
Physical Inactivity
6 Fasting venous blood glucose Random capillary blood glucose QRISK 2 or
JBS 2
AF
Alcohol
Physical Inactivity
7 FindRisc FindRisc QRISK 2 Alcohol
Physical Inactivity
8 Random/Fasting venous blood sample Random capillary blood glucose QRISK 2 AF
Alcohol
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Checks were linked to non-medical support or services.
One PCT commissioned a nurse coordinated multidisci-
plinary family based programme to provide integrated
care for those at high risk of vascular disease within a
community facility. Another used community-based
health trainers to support high risk patients to undertake
‘lifestyle changes’. Two other PCTs had commissioned
programmes specifically for patients diagnosed with pre
diabetes.
Monitoring and Evaluation
There is some standardisation in the monitoring of the
Health Checks Programme as all PCTs are currently
required to submit a minimum dataset to NHS London
(Table 6). Aside from this data, five PCTs reported collect-
ing data on smoking status, alcohol consumption and levels
of physical activity although there was variation in how this
information was quantified. Three PCTs reported collect-
ing data on ‘advice given at the time of the health check’
and four collected data on the ‘number of referrals made’.
Only four PCTS reported collecting data on screening out-
comes such as the number of newly diagnosed cases of dia-
betes, hypertension, chronic kidney disease; and the
number of patients initiated with statin therapy. Only one
PCT was collecting data on the quality of checks.
Discussion
The findings from this survey demonstrate considerable
variation in the implementation of a National Public
Health Programme across eight PCTs within a single sec-
tor of London. The starkest finding was that when bud-
gets were standardised per 100,000 eligible population
there was an apparent twenty-fold difference between the
least and best funded programme. This cannot be fully
explained by a difference in health need across the 8
PCTs. However, when the outlying PCT with the largest
spend was removed we see a strong negative correlation
between the ranked index of deprivation and population-
weighted budget (Table 3) indicating that PCTs responsi-
ble for the most deprived areas spent more per eligible
person than PCTs responsible for more affluent areas.
Interestingly a weak negative correlation was also found
between CHD mortality rates in people under 75 years
per 100,000 and population weighted budget. Such a
degree of variation in funding is likely to result in differ-
ences in the impact of the programme at the population
level.
The study also found other variations in the interpre-
tation and implementation of national policy and gui-
dance. A key consideration is whether these variations
are appropriate and/or whether they contribute to a
postcode lottery effect that is unfair or undesirable.
Universal screening of patients aged between 40 and 74
years is the strategy adopted by the DH to identify and
pro-actively manage individuals at risk of CVD. Some
experts have argued that targeting patients with known
risk factors may be a more cost-effective [9] approach
even though such an approach would identify fewer peo-
ple at-risk [10]. In this study, all PCTs were mostly com-
pliant with the national strategy although there was
considerable variation in the approaches used to ensure
population coverage.
Generally, a systematic as well as a targeted and oppor-
tunistic approach is required to ensure high and equitable
population coverage for screening programmes [7]. A mix
of locations can also be of value. For example, while Gen-
eral Practice is a logical setting on which to base systema-
tic screening programmes, their limited accessibility
outside common working hours can limit uptake. In addi-
tion some sections of the population (e.g. middle-aged,
working class men) are resistant to taking up screening
invitations from GP practices [11]. Offering alternative
sites for screening in the community setting is therefore
sensible, particularly involving pro-active methods to
reach out to men and high-risk groups.
In this study, three PCTs based their Health Checks Pro-
gramme entirely on GP practices, with no outreach or
alternative locations although one of these had carried out
health checks opportunistically at outreach events during
the first year of the programme. The potential for such an
approach to widen health inequalities is significant, given
the fact that a proportion of working class men are both
known to be resistant to preventative health measures pro-
vided at GP practices and at high risk of CVD [12].
The use of two different risk calculation tools may also
result in differences in health outcome at the population
level for reasons described above. In this instance, the var-
iation is less the result of arbitrary or idiosyncratic differ-
ences as all PCTs were compliant with national guidance.
However, the two recommended tools have different levels
of specificity and sensitivity. Most importantly, QRISK2
will identify a smaller number of ‘false positives’ and will
thereby reduce the incidence of iatrogenic harm caused by
statins which increases the risk of liver dysfunction, acute
renal failure, myopathy and cataract [13].
Another significant variation concerns the screening
for diabetes. In theory, two thirds of type 2 diabetes can
be prevented by lifestyle and diet interventions [14], and
Table 6 Current Health Check Data Set Required by DOH
1. Number of people aged 40-74 eligible for an NHS Health Check
2. Number of eligible people who have been offered an NHS Health
Check.
3. Number of eligible people who have received an NHS Health Check.
4. % of eligible people who have been offered a NHS Health Check.
5. % of eligible cohort who have received a NHS Health Check.
Graley et al. BMC Public Health 2011, 11:738
http://www.biomedcentral.com/1471-2458/11/738
Page 5 of 8it is suggested that the Health Checks Programme could
prevent 9,700 case of diabetes a year through the identi-
fication [a] of pre-diabetes and appropriate interventions
[15].
There is however a lack of consensus about the best
population-based approach for detecting undiagnosed
diabetes and pre-diabetes. This is reflected in the national
guidelines which do not make clear recommendations.
RBG tests have been found to produce the lowest yield of
new cases of diabetes. FBG tests are more sensitive and
specific than RBGs (an FBG level of >5.5 mmol/l has a
sensitivity and specificity of 80% and would lead to 20%
of this sub-population requiring a definitive oral glucose
tolerance test). However, FBG tests are more difficult to
conduct and are also not effective at identifying people
with pre-diabetes [13] (sensitivity 51.9%), therefore peo-
ple with pre diabetes may be missed.
The FindRisc tool predicts a future diagnosis of dia-
betes using several factors that are simple to measure
and non invasive. Using a cut off score of 11, FindRisc
has a sensitivity of 66% in men and 77% in women in
detecting diabetes [14]. QDSCORE uses another algo-
rithm for estimating the risk of developing type 2 dia-
betes over a 10-year period although it is yet to be
clinically validated [16].
The differences in the sensitivity and specificity of the
various screening approaches and tests for diabetes will
impact on the number of new cases of diabetes and pre
diabetes identified through the Health Checks Programme.
Given the lack of a standardised approach across the eight
PCTs, this is likely in turn to result in differences in the
effectiveness and efficiency of the programme.
The success of the Health Checks Programme is ulti-
mately dependent not just on achieving high and targeted
population coverage but also upon the quality of CVD risk
management, including behaviour change interventions.
Here it is evident that the quality, cost and effectiveness of
such interventions vary considerably between PCTs (and
are likely to vary within PCTs). For this reason, systems of
evaluation that are capable of monitoring the quality of
post-screening counselling, advice and clinical manage-
ment are important.
Presently, there is strong guidance on the collection of a
minimum national dataset. However, none of these data
provide any information on quality or outcome and this
survey found both varied and limited attempts by PCTs to
collect data on the quality and impact of the Health
Checks Programme, with only one PCT monitoring qual-
ity. Given that the monitoring and evaluation of quality
and impact is an important ingredient of programmatic
effectiveness in its own right, the lack and variability of
monitoring and evaluation raises further concerns about
the existence of a postcode lottery effect.
The survey also highlighted some variation which may
not necessarily contribute to a postcode lottery effect.
For example, variation in the payment made to GPs and
pharmacies may not have a discernible impact on qual-
ity or outcomes, and may be explained in part by differ-
ences in the terms and conditions of contracts (e.g.
w h e t h e ro rn o tc o n s u m a b l e sa r es u p p l i e db yt h eP C T ) .
Similarly, we found differences in the availability of
referral services and decisions taken to piggy-back addi-
tional public health interventions - but such differences
cannot be assumed to result in differences in health out-
comes without a broader understanding of other ser-
vices and programmes provided by each PCT.
Limitations
The main limitation of this study is that data on differ-
ences in the quality and impact of the Health Check Pro-
gramme are not available. Another limitation of the study
is that other programmes or initiatives to assess and man-
age CVD risks were not taken into consideration. For
example, in one of the eight PCTs, a well-funded pro-
gramme to manage CVD exists and has some overlap with
the Health Checks Programme. Finally, a third limitation
is that this study is focused on a small geographical area
within London and is not representative of the country.
However the fact that there are such large variations
within a small area reinforces the likelihood of a consider-
able postcode lottery effect associated with the Health
Checks Programme.
Conclusion
The clinical policies and eligibility criteria for NHS
screening programmes are usually uniform, standardised
and evidence-based. Operational guidelines are provided
to help avoid any postcode lottery effect, as well as to
inform clinical providers with the latest evidence and to
help ensure the best provision of care [17].
However, this study identifies a postcode lottery effect
related to a national public health programme aimed at
reducing the incidence of CVD. Furthermore, it shows
this effect within a single geographical sub-sector of
London, which may suggest even greater variation at a
national level. The study raises questions about the bal-
ance between having nationally prescribed standards
and guidelines (to prevent undesirable variation in prac-
tice or outcomes) and allowing local discretion and flex-
ibility (to allow programmes to be tailored to local
factors).
The study also suggests a lack of joint planning and
sharing of information between PCTs within the same
locality which could have helped minimise a postcode
lottery effect, as well as achieved certain economies of
scale (e.g. through the joint procurement of equipment).
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PCTs to take steps towards greater harmonization, as
well as to improve the quality of local monitoring and
evaluation.
Although it is important to allow some flexibility in
the design of the Health Checks Programme, some
aspects of the programme might benefit from greater
standardisation or stronger guidance. For example, it
would seem beneficial to have clearer guidelines around
the choice of risk calculator to estimate CVD risk and
of screening approach for diabetes. Stronger guidance
could also be supplied by the DH with regard to moni-
toring and evaluation that goes beyond the national
minimum data set. Importantly, this would include gui-
dance on the periodic (non-routine) collection of data
on quality, as well as the use of participatory or action
research methods that would promote continuous qual-
ity improvement.
This study therefore suggests a need for a more struc-
tured approach towards getting the balance right between
nationally prescribed guidelines and standards that
are mandatory, national guidance that is non-mandatory
and programmatic elements that are left entirely to local
discretion. The application of such an approach to the
Health Checks Programme is shown in Table 7. While
this approach may help minimise a postcode lottery
effect, it should be noted that a trade-off between the
benefits of complete standardisation and/or equity and
the benefits of allowing local discretion and flexibility
may be unavoidable.
Endnotes
a. This is based on the assumption that checks would
include all questions that make up the FINDRISC score
a n dt h a tp e o p l ew i t hah i g hF I N D R I S Cs c o r ew o u l d
receive an initial blood glucose test and those with a
value over 6 would be called back to receive and oral
glucose tolerance test.
b. This budget covers the costs of carrying out NHS
Health Checks and relates to the costs of buying equip-
ment to carry out the health checks, payments made to
providers for carrying out checks and the costs of mar-
keting the service.
c. Rank of deprivation out of 326 LA’s nationally
based on IMD scores in 2010 (most deprived to least)
d. Directly Standardised Rate of Coronary Heart Dis-
ease Mortality In Persons Aged under 75 per 100,000
population by PCT, 2006-2008 pooled [18]
e. MHRA Report 05051 2005: Polymer Technology
Systems CardioChek PA Lipid System
f. MDA Evaluation Report 1995: Cholestech LDX
Lipid Analyzer, MDA/95/23
Table 7 Programmatic Elements to be Nationally Prescribed, Encouraged Nationally, or Left to Local Discretion
Nationally prescribed guidelines and standards
that are mandatory
National guidance that is non-
mandatory
Programmatic elements
that are entirely left to
local discretion
Eligibility for
Health Check
Eligibility criteria in terms of age and ethnicity, with
some allowance for clinical discretion
Approach to
achieving
coverage
Stipulate use of both systematic and opportunistic
approaches; as well as GP and non-GP settings (to
avoid increasing inequity)
Minimum coverage targets
Provide guidance on how systematic
screening should be organised annually.
Provide suggested targets for non-GP
screening
Identification of non-GP
settings and opportunistic
approaches
Funding and
payment
structure
Guidance on payment rates per Health
Check
Suggested minimum and maximum cost
of the programme per 100,000 population
Equipment and
screening
instruments
CVD Risk Calculation Tool POCT equipment that is accredited by
MHRA
Approach to diabetes and pre diabetes
screening
Procurement of POCT.
Additional
Interventions
Recommended additional screening tests
that could be part of a Health Check
Recommended method or tools for
additional screening (e.g. AUDITc for
alcohol screening)
Final selection of additional
screening tests and tools
Monitoring and
evaluation
Mandatory minimum dataset
Minimum requirements for evaluation of quality and
outcomes.
Guidance on suggested methods for
evaluation of quality and outcomes.
including an equity analysis
Final design of M&E strategy
Referral
Pathways
Referral criteria and expectations for clinical
conditions requiring medical attention
Best practice referral guidelines for weight
management, smoking cessation, etc
Design of local referral
pathways and commissioning
of required services
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Page 7 of 8Additional material
Additional file 1: Structured Questionnaire. Structured questionnaire
covered the following aspects of the Health Checks Programme:
eligibility criteria; approach used to ensure population coverage; funding
and associated payment structures; equipment and screening
instruments; CVD risk calculation tool used; additional interventions;
monitoring and evaluation; and advice treatment and referrals.
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